Gastrointestinal Stromal Tumor

Almost 30 years have gone by since the postulation that GISTs derive from mesenchymal stem elements, and only 15 years have gone by since the definitive detection of origin of GISTs. Research in the last decade was more focused upon the justification of imatinib mezylate therapy in GISTs and clarifi...

Full description

Saved in:
Bibliographic Details
Other Authors: Lunevicius, Raimundas (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2012
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_66052
005 20210420
003 oapen
006 m o d
007 cr|mn|---annan
008 20210420s2012 xx |||||o ||| 0|eng d
020 |a 1892 
020 |a 9789535105800 
020 |a 9789535169871 
040 |a oapen  |c oapen 
024 7 |a 10.5772/1892  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Lunevicius, Raimundas  |4 edt 
700 1 |a Lunevicius, Raimundas  |4 oth 
245 1 0 |a Gastrointestinal Stromal Tumor 
260 |b IntechOpen  |c 2012 
300 |a 1 electronic resource (132 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Almost 30 years have gone by since the postulation that GISTs derive from mesenchymal stem elements, and only 15 years have gone by since the definitive detection of origin of GISTs. Research in the last decade was more focused upon the justification of imatinib mezylate therapy in GISTs and clarification why a secondary resistance that occurred during the kinase inhibitors therapy. The era of therapy for GISTs, targeting the primary activating mutations in the KIT proto-oncogene; is being proclaimed as bringing the message of special importance to the pathologist role in multidisciplinary team that are responsible for treating patients with locally advanced or metastatic GIST. This is the first conclusive message forthcoming from this book. On the other hand, the book provides summarised and case-based knowledge on current management of gastrointestinal and extragastrointestinal stromal tumours. We hope that this book may be considered as a worthwhile timely addition to clinical science dissemination, medical education, further basic and clinical research. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a Oncology 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/1432/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/66052  |7 0  |z DOAB: description of the publication